Literature DB >> 12848944

Systemic sclerosis: current views of its pathogenesis.

Chris T Derk1, Sergio A Jimenez.   

Abstract

Systemic sclerosis (SSc) is an autoimmune disorder of unknown etiology characterized by severe and often progressive cutaneous and visceral fibrosis, pronounced alterations in the microvasculature, and numerous cellular and humoral immune abnormalities. Clinically, SSc is very heterogeneous, encompassing a spectrum ranging from mild limited forms of skin sclerosis with minimal internal organ involvement to severe skin and multiple internal organ fibrosis. Mortality and morbidity in SSc are very high and are directly related to the extent of the fibrotic and microvascular alterations. A better understanding of the pathogenesis of this incurable disorder will help to better target and design effective therapy in the future.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12848944     DOI: 10.1016/s1568-9972(03)00005-3

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  31 in total

Review 1.  The epigenetics of autoimmunity.

Authors:  Francesca Meda; Marco Folci; Andrea Baccarelli; Carlo Selmi
Journal:  Cell Mol Immunol       Date:  2011-01-31       Impact factor: 11.530

2.  Dramatic progression of skin involvement in systemic sclerosis after the appearance of anti-Scl70 antibody: a case report.

Authors:  Paola Caramaschi; Alessandro Volpe; Antonio Carletto; Lisa Maria Bambara; Domenico Biasi
Journal:  Rheumatol Int       Date:  2007-08-10       Impact factor: 2.631

3.  Test--retest reliability of Oral Health Impact Profile (OHIP-49) in adults with systemic sclerosis.

Authors:  Hon K Yuen; Sybil L Nelson
Journal:  Spec Care Dentist       Date:  2013-06-19

4.  Factors associated with oral hygiene practices among adults with systemic sclerosis.

Authors:  H K Yuen; F N Hant; C Hatfield; L M Summerlin; E A Smith; R M Silver
Journal:  Int J Dent Hyg       Date:  2013-10-15       Impact factor: 2.477

5.  A multimodal ophthalmic analysis in patients with systemic sclerosis using ocular response analyzer, corneal topography and specular microscopy.

Authors:  Huseyin Mayali; Muhammed Altinisik; Secil Sencan; Timur Pirildar; Emin Kurt
Journal:  Int Ophthalmol       Date:  2019-09-28       Impact factor: 2.031

6.  What is the relationship between disease activity, severity and damage in a large Canadian systemic sclerosis cohort? Results from the Canadian Scleroderma Research Group (CSRG).

Authors:  Xiangning Fan; Janet Pope; Murray Baron
Journal:  Rheumatol Int       Date:  2009-09-24       Impact factor: 2.631

7.  Factors associated with gingival inflammation among adults with systemic sclerosis.

Authors:  H K Yuen; Y Weng; S G Reed; L M Summerlin; R M Silver
Journal:  Int J Dent Hyg       Date:  2013-04-24       Impact factor: 2.477

8.  Skewed X-chromosome inactivation in scleroderma.

Authors:  Elif Uz; Laurence S Loubiere; Vijayakrishna K Gadi; Zeynep Ozbalkan; Jeffrey Stewart; J Lee Nelson; Tayfun Ozcelik
Journal:  Clin Rev Allergy Immunol       Date:  2008-06       Impact factor: 8.667

9.  Histomorphometric analysis of cutaneous remodeling in the early stage of the scleroderma model.

Authors:  Cristiane Carla de Oliveira; Ana Paula Pereira Velosa; Edwin Roger Parra; Vera Luiza Capelozzi; Walcy Rosolia Teodoro; Natalino Hajime Yoshinari
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

10.  Scleroderma, stress and CAM utilization.

Authors:  Ka-Kit Hui; Michael Francis Johnston; Marc Brodsky; Joe Tafur; Mai Kim Ho
Journal:  Evid Based Complement Alternat Med       Date:  2007-10-25       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.